
AIIMS Delhi Seeks Action Taken Report Within 7 Days On Orders Issued By Director
- byDoctor News Daily Team
- 18 February, 2025
- 0 Comments
- 0 Mins

New Delhi: For the purpose of monitoring the progress of the work laid down by the newly appointed Director Dr M Srinivas, All India Institute of Medical Sciences (AIIMS), New Delhi, the premier institute has asked all its departments to file an action taken report on various orders and instructions within 7 days.
Over the past months, the director has issued various orders and instructions to ensure the smooth functioning of the institute. Now, the institute has requested that all department heads provide an update on the status of their ongoing work. The report will give a clear understanding of how the institute will function in the coming years.
In an office memorandum issued on November 24 by Dr R Gopinath, deputy secretary, it said "I am directed to request all concerned to submit an Action Taken Report within a period of 7 days so as to review the progress. CSO and the SE may submit updates on the ATR already furnished."
Various orders/ instructions pertaining to different issues have been issued by the Director, AIIMS, New Delhi for smooth functioning of this institute. Enclosed please find the gist of instructions/ orders issued till 31.10.2022 with authorities/agencies responsible indicated therein, against each issue, reads the memorandum.
Also read- AIIMS E-Hospital Server Down: Fresh Guidelines Issued For Manual Admission Of Patients
After being appointed as the new director of the institute on September 23, Dr Srinivas has issued a slew of measures over the past months to upgrade and ensure the smooth functioning of the institute.
Implementation of the various orders passed by the director includes punctuality in attendance, implementation of an e-office, battery-powered buses for internal transport within the campus, streamlining of patients at the New Rajkumari Amrit Kaur (RAK) outpatient department, contractual staff to remain on seats during duty hours etc.
team had earlier also reported on various orders implemented by the institute including E-hospital, patient referral system, call centre facility for attendants of ICU patients and many more.
Recently, AIIMS has granted beneficiaries under the Employees Health Scheme (EHS) to get the "self-prescription" facility for some specific over-the-counter drugs starting next year. The move would come into effect from 1st January 2023, which would help them to skip over the tedious process of waiting in long queues and going through registration and consultation to get medicines.
Also read- AIIMS Delhi Grants Self-Prescription Facility For EHS Beneficiaries From Next Year
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:

Recent News
Normal-Tension Glaucoma Closely Associated With Co...
- 10 October, 2022
Air Pollution Tied To Increased Risk Of Premature...
- 24 May, 2023
NEET PG 2024: NBE Opens Pre-Final Edit Window
- 30 May, 2024
NMC Mulls Over Removal Of Upper Age Cap In MBBS En...
- 30 November, 2021

Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!